Coronavirus Disease (COVID-19): Pathogenicity, Transmission, Epidemiology, Diagnosis, Case Management and Public Health Response

Main Article Content

O. J. Adenola
M. O. Elabiyi

Abstract

The spread of Coronavirus Disease 2019 (COVID-19) to almost every part of the globe making it a global pandemic as resulted to be a global crisis with urgent need of innovative research ideas, mechanisms and strategy to treat, curtail, contain and prevent the spread of the disease. Covid-19 caused by a novel virus SARS-CoV-2. Leaders around the world have being engaging researchers and scientists for possible vaccine for COVID-19. This pandemic has caused instability in social, economy and psychological balance around the world which has resulted to a new way of life (new normal) which might not return to former normal soon. COVID-19 was declared as a global health emergency that poses threat to humanity, hence, it becomes imperative to abridge and ameliorate its effect, as we await the flattening of the pandemic curve and vaccine development. This review summarizes and provides meaningful information for recent and future research related to the viral origin, epidemiology, transmission, pathogenicity, clinical manifestation and diagnosis, management, prevention and control of coronavirus. All countries in the world and all concerned stakeholders should increase the awareness and provide necessary strategies holistically at the community, state, region, national and international levels to combat this disease.

Keywords:
COVID-19, pandemic, epidemiology, transmission, pathogenicity, clinical manifestation, prevention and control measure

Article Details

How to Cite
Adenola, O. J., & Elabiyi, M. O. (2020). Coronavirus Disease (COVID-19): Pathogenicity, Transmission, Epidemiology, Diagnosis, Case Management and Public Health Response. Asian Journal of Research and Reports in Gastroenterology, 3(2), 15-21. Retrieved from http://journalajrrga.com/index.php/AJRRGA/article/view/30108
Section
Minireview Article

References

Li H, Liu SM, Yu XH, et al. Coronavirus disease 2019 (COVID-19): Current status and future perspective. Int. J. Antimicrob Agents. 2020;2019:105951.

DOI: 10.1016/j.ijantimicag.2020.105951

Arshad Ali S, Baloch M, Ahmed N, Arshad Ali A, Iqbal A. The outbreak of Coronavirus Disease 2019 (COVID-19)-An emerging global health threat. J. Infect Public Health; 2020.

Adhikari S, Meng S, Wu Y, et al. Epidemiology, causes, clinical manifestation and diagnosis, prevention and control of Coronavirus Disease (COVID-19) during the early outbreak period: A scoping review. Infect Dis Poverty. 2020;9:29.

Serge R, Vandromme J, Charlotte M. Are we equal in adversity? Does COVID-19 affect women and men differently? Maturitas; 2020.

Sanders JM, Monogue ML, Jodlowski TZ, Cutrell JB. Pharmacologic treatments for Coronavirus Disease 2019 (COVID-19): A review. JAMA. 2020;323(18):1824–1836.

Pal M, Berhanu G, Desalegn C, Kandi V. Severe acute respiratory syndrome Coronavirus-2 (SARS-CoV-2): An update. Cureus. 2020;12:e7423.

Romano M, Ruggiero A, Squeglia F, Maga G, Berisio RA. Structural view of SARS-CoV-2 RNA replication machinery: RNA synthesis, proofreading and final capping. Cells; 2020.

Giordano G, Blanchini F, Bruno R, et al. Modelling the COVID-19 epidemic and implementation of population-wide interventions in Italy. Nat Med. 2020;26: 855–860.

Adhikari S, Meng S, Wu Y, et al. Epidemiology, causes, clinical manifestation and diagnosis, prevention and control of Coronavirus Disease (COVID-19) during the early outbreak period: A scoping review. Infect Dis Poverty. 2020;9:29.

Galbadage T, Peterson BM, Gunasekera RS. Does COVID-19 spread through droplets alone? Front. Public Health. 2020; 8:163.

Hamid S, Mir MY, Rohela GK. Novel Coronavirus Disease (COVID-19): A pandemic (epidemiology, pathogenesis and potential therapeutics). New Microbes New Infect. 2020;35:100679.

DOI: 10.1016/j.nmni.2020.100679

Stephen A. Lauer, Kyra H. Grantz, Qifang Bi, Forrest K. Jones, Qulu Zheng, Hannah R. Meredith, Andrew S. Azman, Nicholas G. Reich, Justin Lessler. The incubation period of Coronavirus Disease 2019 (COVID-19) from publicly reported confirmed cases: Estimation and application. Annals of Internal Medicine. 2020;172(9):577-582.

Li R, et al. Substantial undocumented infection facilitates the rapid dissemination of novel coronavirus (SARS-CoV2). Science; 2020.

DOI: 10.1126/science.abb3221.

Jalava K. First respiratory transmitted food borne outbreak? International Journal of Hygiene and Environmental Health, 2020; 226:113490.

Liu T, et al. Transmission dynamics of 2019 novel Coronavirus (2019-nCoV). The Lancet; 2020.

Available:https://ssrn.com/abstract=3526307

Zhong NS, Zheng BJ, Poon YM, Xie ZH, Chan KH, et al. Epidemiology and cause of Severe Acute Respiratory Syndrome (SARS) in Guangdong, People’s Republic of Chinese in February, 2003. Lancet. 2003;326(9393):1353-8.

Centers for disease control and prevention (CDC). Novel coronavirus, Wuhan, China; 2020.

Available:https://www.Cdc.gov/.coronavirus/2019 – n Co V/ summary.html

Accessed June, 2020.

Chen H, Guo J, Wang C, Luo F, Yu X, Zhang W, Li J, Zhao Xu D, Gong Q, et al. Clinical characteristics and intrauterine vertical transmission potential of COVID-19 infection in nine pregnant women: A retrospective review of medical records. The Lancet; 2020.

Guan W, Ni Z, Hu Y, Liang W, Ou C, He J, Liu L, Shan H, Lei C, Hui DS, et al. Clinical characteristics of 2019 novel coronavirus infection in china. MedRxiv; 2020.

World Health Organization (WHO). Novel Coronavirus (2019-nCoV). WHO Bull. 2020;1–7.

World Health Organization (WHO). O. Novel Coronavirus–China; 2020.

Available:https://www.who.int/csr/don/12-january-2020-novel-coronavirus-china/en/

Accessed 12 June, 2020.

World Health Organization. Infection prevention and control of epidemic- and pandemic-prone acute respiratory infections in health care. Geneva: World Health Organization; 2014.

Available:https://apps.who.int/iris/bitstream/handle/10665/112656/9789241507134_eng.pdf?sequence=1

Accessed 12 June, 2020.

Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y et al, Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: A descriptive study. Lancet. 2020; 395:507–13.

Zeng ZQ, Chen DH, Tan WP, Qiu SY, Xu D, Liang HX, Chen MX, Li X, Lin ZS, Liu WK, et al. Epidemiology and clinical characteristics of human coronaviruses oc43, 229e, nl63, and hku1: A study of hospitalized children with acute respiratory tract infection in guangzhou, china. European Journal of Clinical Microbiology & Infectious Diseases. 2018;37(2):363–369.

Hu C Song, Xu C, Jin G, Chen Y, Xu X, Ma H, Chen W, Lin Y, Zheng Y, et al. Clinical characteristics of 24 asymptomatic infections with COVID-19 screened among close contacts in nanjing, china. Science China Life Sciences. 2020;1–6.

Song HD, Zhang GW, Wang SY, Zheng K, Lei LC, et al. Cross-host evolution of severe acute respiratory syndrome corona virus in palm dvet and human. Proc. NatI Acad Sci USA. 2005;102(7):2430-5.

Zhou P, Yang XL, Wang XG, Hu B, Zhang L, Zhang W, et al, Discovery of a novel coronavirus associated with the recent pneumonia outbreak in humans and its potential bat origin. Bio Rxiv; 2020.

DOI:https://doi.org/10.1101/2020.01.22.914952

Chinese SARS Molecular Epidemiology Consortium. Molecular evolution of the SARS coronavirus during the course of the SARS epidemic in China. Science. 2004; 303(5664):1666–9.

Lu H. Drug treatment options for the 2019-new coronavirus (2019-nCoV). Biosci; Trends; 2020.

DOI: 10.5582/bst.2020.01020

Hui, et al. Clinical characteristics of 2019 novel coronavirus infection in china. Med. Rxiv; 2020.

Huang C, Wang Y, Li X, Ren L, Zhao Jianping, Hu Y, et al, Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395:497–506.

WHO. Summary and risk assessment of current situation in Republic of Korea and China; 2015.

Available:http://www.Who.int/isr/disease/coronavirus _Infections/ risk assessment -19 june 2015/en/

Wang P, Lu J, Jin Y, Zhu M, Wang L, Chen S. Epidemiological characteristics of 1212 COVID-19 patients in henan, china. Med Rxiv; 2020.

Forni D, Cagliani R, Clerici M, Sironi M. Molecular evolution of human coronavirus genomes. Trends Microbiol. 2017;25:35–48.

Singh Yashpal, Sircar Shubhankar, Bhat Sudipta, Sharun Khan, Dhama Kuldeep, Dadar Maryam, Tiwari Ruchi, Chaicumpa. Emerging novel Coronavirus (2019-nCoV) -Current scenario, evolutionary perspective based on genome analysis and recent developments. Vet. Q. 2020;40(1):1–12.

Huang CL, et al. The Lancet; 2020.

Available:https://doi.org/10.1016/S0140-6736 (20)30183-5

Gralinski LE, Menachery VD. Return of the coronavirus: 2019-nCoV. Viruses. 2020;12:135.

World Health Organization. Infection prevention and control for novel Coronavirus (COVID-19) Course; 2020.

Available:https://openwho.org/courses/COVID-19-IPC-EN

World Health Organization. Infection prevention and control guidance for long-term care facilities in the context of COVID-19. Interim guidance. Geneva, World Health Organization; 2020.

Centers for disease control and prevention (CDC). Interim infection prevention and control recommendations for patients with suspected or confirmed Coronavirus Disease 2019 (COVID-19) in Healthcare Settings; 2020.

Available:https://www.cdc.gov/coronavirus/2019-ncov/infectioncontrol/control-recommendations.html

World Health Organization (WHO). Director General’s remarks at the media briefing on 2019 novel corona virus; 2020.

Available:https://www.who.int/dg/speeches/detail/director-general-s-remarks-at-the-media-briefing-on-2019-novel-corona virus—8-febuary- 2020

WHO Social Stigma associated with COVID-19. A guide to preventing and addressing social stigma’ 2020.

Available:https://www.who.int/docs/defaulSt-source/coronaviruse/covid19-stigma-guide.pdf